MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimanyi, I.
Right arrow Articles by Pessah, I. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimanyi, I.
Right arrow Articles by Pessah, I. N.

Ryanodine induces persistent inactivation of the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum

I Zimanyi, E Buck, JJ Abramson, MM Mack and IN Pessah

Department of Veterinary Pharmacology and Toxicology, University of California, Davis 95616.

Junctional sarcoplasmic reticulum (SR) membranes isolated from rabbit skeletal muscle were pretreated with 0.1-500 microM ryanodine under equilibrium conditions optimal for receptor binding, followed by the removal of bound alkaloid by several washes in Ca(2+)- and ryanodine- free buffer. Pretreatment with > 100 nM ryanodine results in a concentration-dependent decrease in the Bmax of the high affinity sites and a complete loss of measurable low affinity binding sites that persist for > 48 hr. Quantitative analysis of residual ryanodine using three different methods demonstrates that the inhibition is not the result of residual ryanodine bound to its receptor. Ca2+ transport measurements made with antipyrylazo III show that actively loaded ryanodine-pretreated SR exhibits a persistent insensitivity to ryanodine- and daunomycin-induced Ca2+ release that is not seen with washed control vesicles. Lipid bilayer membranes fused with SR vesicles exhibit rapidly fluctuating single-channel events with a conductance of 468 pS in asymmetric CsCl solutions. Ryanodine (10 microM) produces a unidirectional transition to a slowly fluctuating half-conductance state that is not reversed by perfusion of the bilayer with Ca(2+)-free buffer and subsequent addition of dithiothreitol. However, dithiothreitol added in the ryanodine pretreatment medium offers marked protection against ryanodine-induced loss of binding sites and allows complete restoration of native gating behavior of single channels in bilayer lipid membrane. Using three different experimental approaches, the data demonstrate that the alkaloid at micromolar concentration persistently alters SR Ca2+ release channel function, perhaps by uncoupling four negatively cooperative binding sites. The oxidation of critical receptor thiols is implicated in the process.

Volume 42, Issue 6, pp. 1049-1057, 12/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
G. Cherednichenko, C. W. Ward, W. Feng, E. Cabrales, L. Michaelson, M. Samso, J. R. Lopez, P. D. Allen, and I. N. Pessah
Enhanced Excitation-Coupled Calcium Entry in Myotubes Expressing Malignant Hyperthermia Mutation R163C Is Attenuated by Dantrolene
Mol. Pharmacol., April 1, 2008; 73(4): 1203 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. Yang, E. Esteve, I. N. Pessah, T. F. Molinski, P. D. Allen, and J. R. Lopez
Elevated resting [Ca2+]i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1591 - C1598.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. A. Ta, W. Feng, T. F. Molinski, and I. N. Pessah
Hydroxylated Xestospongins Block Inositol-1,4,5-trisphosphate-Induced Ca2+ Release and Sensitize Ca2+-Induced Ca2+ Release Mediated by Ryanodine Receptors
Mol. Pharmacol., February 1, 2006; 69(2): 532 - 538.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Hurne, J. J. O'Brien, D. Wingrove, G. Cherednichenko, P. D. Allen, K. G. Beam, and I. N. Pessah
Ryanodine Receptor Type 1 (RyR1) Mutations C4958S and C4961S Reveal Excitation-coupled Calcium Entry (ECCE) Is Independent of Sarcoplasmic Reticulum Store Depletion
J. Biol. Chem., November 4, 2005; 280(44): 36994 - 37004.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Gao, A. A. Voss, I. N. Pessah, F. T. Lauer, T. M. Penning, and S. W. Burchiel
Ryanodine Receptor-Mediated Rapid Increase in Intracellular Calcium Induced by 7,8-Benzo(a)Pyrene Quinone in Human and Murine Leukocytes
Toxicol. Sci., October 1, 2005; 87(2): 419 - 426.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Jordan, H. Jiang, H. Li, and J. X. DiMario
Inhibition of ryanodine receptor 1 in fast skeletal muscle fibers induces a fast-to-slow muscle fiber type transition
J. Cell Sci., December 1, 2004; 117(25): 6175 - 6183.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Cherednichenko, A. M. Hurne, J. D. Fessenden, E. H. Lee, P. D. Allen, K. G. Beam, and I. N. Pessah
Conformational activation of Ca2+ entry by depolarization of skeletal myotubes
PNAS, November 2, 2004; 101(44): 15793 - 15798.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
C. S. Hui, H. R. Besch Jr., and K. R. Bidasee
Effects of Ryanoids on Spontaneous and Depolarization-Evoked Calcium Release Events in Frog Muscle
Biophys. J., July 1, 2004; 87(1): 243 - 255.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Shtifman, C. Paolini, J. R. Lopez, P. D. Allen, and F. Protasi
Ca2+ influx through {alpha}1S DHPR may play a role in regulating Ca2+ release from RyR1 in skeletal muscle
Am J Physiol Cell Physiol, January 1, 2004; 286(1): C73 - C78.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Yang, T. A. Ta, I. N. Pessah, and P. D. Allen
Functional Defects in Six Ryanodine Receptor Isoform-1 (RyR1) Mutations Associated with Malignant Hyperthermia and Their Impact on Skeletal Excitation-Contraction Coupling
J. Biol. Chem., July 3, 2003; 278(28): 25722 - 25730.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Fill and J. A. Copello
Ryanodine Receptor Calcium Release Channels
Physiol Rev, October 1, 2002; 82(4): 893 - 922.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Fessenden, L. Chen, Y. Wang, C. Paolini, C. Franzini-Armstrong, P. D. Allen, and I. N. Pessah
Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine
PNAS, February 8, 2001; (2001) 41608898.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
N. J. Willmott, K. Wong, and A. J. Strong
A Fundamental Role for the Nitric Oxide-G-Kinase Signaling Pathway in Mediating Intercellular Ca2+ Waves in Glia
J. Neurosci., March 1, 2000; 20(5): 1767 - 1779.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Zucchi, G. Yu, P. Galbani, M. Mariani, G. Ronca, and S. Ronca-Testoni
Sulfhydryl Redox State Affects Susceptibility to Ischemia and Sarcoplasmic Reticulum Ca2+ Release in Rat Heart : Implications for Ischemic Preconditioning
Circ. Res., November 2, 1998; 83(9): 908 - 915.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. T. Sudo and T. E. Nelson
Changes in Ryanodine-Induced Contractures by Stimulus Frequency in Malignant Hyperthermia Susceptible and Malignant Hyperthermia Nonsusceptible Dog Skeletal Muscle
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1331 - 1336.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
R. Zucchi and S. Ronca-Testoni
The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States
Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Sierralta, M. Fill, and B. A. Suarez-Isla
Functionally Heterogenous Ryanodine Receptors in Avian Cerebellum
J. Biol. Chem., July 19, 1996; 271(29): 17028 - 17034.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Fessenden, L. Chen, Y. Wang, C. Paolini, C. Franzini-Armstrong, P. D. Allen, and I. N. Pessah
Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine
PNAS, February 27, 2001; 98(5): 2865 - 2870.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics